Aspruzyo Sprinkle
NDC Package 47335-624-60

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Aspruzyo Sprinkle is indicated for the treatment of chronic angina.ASPRUZYO Sprinkle may be used with beta-blockers, nitrates, calcium channel blockers, anti‑platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers. Marketed by Sun Pharmaceutical Industries, Inc., this product is identified by NDC 47335-624 and is authorized under FDA application NDA216018.

Identification & Billing

NDC Package Code
47335-624-60
Package Description
60 GRANULE in 1 CARTON
Product Code
47335-624
11-Digit Billing Format
47335062460
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
60 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Aspruzyo Sprinkle
Dosage Form
-
Usage Information
ASPRUZYO Sprinkle is indicated for the treatment of chronic angina.ASPRUZYO Sprinkle may be used with beta-blockers, nitrates, calcium channel blockers, anti‑platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers.

Regulatory & Marketing

Labeler Name
Sun Pharmaceutical Industries, Inc.
FDA Application #
NDA216018
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
02-28-2022
End Marketing Date
04-30-2024
Listing Expiration
04-30-2024
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (47335-624). Click a package code to view its specific billing and regulatory data.

47335-624-11
1 GRANULE in 1 PACKET
47335-624-30
30 GRANULE in 1 CARTON

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 47335-624-60 identifies a specific commercial package of 60 granule in 1 carton of Aspruzyo Sprinkle, labeled by Sun Pharmaceutical Industries, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 60 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sun Pharmaceutical Industries, Inc. on February 28, 2022. The current certification is valid through April 30, 2024.

How is this Sun Pharmaceutical Industries, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 47335062460. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
47335-624-60
11-Digit CMS (5-4-2)
47335-0624-60

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.